Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children

Emergent SARS-CoV-2 variants and waning humoral immunity in vaccinated individuals have resulted in increased infections and hospitalizations. Children are not spared from infection nor complications of COVID-19, and the recent recommendation for boosters in individuals ages 12 years or older calls...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Madeleine D. Burns, Brittany P. Boribong, Yannic C. Bartsch, Maggie Loiselle, Kerri J. St. Denis, Maegan L. Sheehan, Jessica W. Chen, Jameson P. Davis, Rosiane Lima, Andrea G. Edlow, Alessio Fasano, Alejandro B. Balazs, Galit Alter, Lael M. Yonker
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2022-03-01
Series:Vaccines
Assuntos:
SARS-CoV-2
COVID-19
pediatrics
adolescents
vaccines
boosters
Acceso en liña:https://www.mdpi.com/2076-393X/10/4/492
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares